Acmeglim-MV 2/0.3 Tablet SR
Marketer
Acmedix Pharma LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Acmeglim-MV 2/0.3 Tablet SR
Diabex Duo 2/0.3 mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo 2/0.3 mg ER tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan, including dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to counter them with a fast-acting glucose source like fruit juice or glucose tablets. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of cardiovascular disease to your doctor before initiating treatment. Consult your physician before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Acmeglim-MV 2/0.3 Tablet SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Acmeglim-MV 2/0.3 Tablet SR
Managing Type 2 diabetes
Major Benefits of Acmeglim-MV 2/0.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Acmeglim-MV 2/0.3 Tablet SR on an empty stomach.
Common Side effects of Acmeglim-MV 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Acmeglim-MV 2/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Acmeglim-MV 2/0.3 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Acmeglim-MV 2/0.3 Tablet SR works:
Acmeglim-MV 2/0.3 sustained-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Acmeglim-MV 2/0.3 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Acmeglim-MV 2/0.3 SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Acmeglim-MV 2/0.3 mg tablet is likely not safe for breastfeeding mothers. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Acmeglim-MV 2/0.3 SR tablets in individuals with kidney impairment carries a significant risk and is best avoided. A physician's consultation is advised. Furthermore, this medication is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Acmeglim-MV 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Acmeglim-MV 2/0.3 Tablet SR :
Should you forget to take your Acmeglim-MV 2/0.3 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Acmeglim-MV 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently